Enzox-Forte Tablet contains Pancreatin 220mg, a combination of digestive enzymes including amylase, lipase, and protease, designed to aid in the digestion of carbohydrates, fats, and proteins respectively. It is indicated for patients with pancreatic insufficiency resulting from conditions such as chronic pancreatitis, cystic fibrosis, pancreatic surgery, or other disorders impairing pancreatic enzyme production. By supplementing endogenous enzymes, Enzox-Forte facilitates improved nutrient absorption and alleviates symptoms associated with malabsorption, including steatorrhea, bloating, and abdominal discomfort. The recommended dosage should be individualized based on the severity of enzyme deficiency and dietary fat intake, with administration typically occurring during or immediately after meals to optimize enzymatic activity. Caution is advised in patients with known hypersensitivity to pancreatin or any component of the formulation. Adverse effects are generally mild and may include gastrointestinal disturbances such as nausea, abdominal pain, or allergic reactions in rare cases. Enzox-Forte should be used under medical supervision, particularly in patients with pre-existing conditions such as gout or renal impairment. Proper storage conditions should be maintained to preserve enzyme potency. This medication is an essential adjunct in managing pancreatic exocrine insufficiency, improving quality of life through enhanced digestion and nutrient assimilation.